Interleukins, Lymphokines and Related Peptides
Home > Products >Catalog Peptides >Interleukins, Lymphokines and Related Peptides

Interleukins, Lymphokines and Related Peptides

* Please be kindly noted that our product can only be used for research to organizations or companies and not intended for individuals.

Browse products name by alphabetical order:

Cat. # Product Name Price
I03001IL-1β (178-207) (human)Inquiry
I03002(D-Pro194)-IL-1β (193-195) (human)Inquiry
I03003IL-1β (208-240) (human)Inquiry
I03004IL-8 InhibitorInquiry
I03005IL-1α (223-250) (human)Inquiry
I03006IL-1β (163-171) (human)Inquiry
I03007IL-6 (88-121) (human)Inquiry
I03008IL-8 (-5 to +5)Inquiry
I03010rec Endothelial IL-8 (human)Inquiry
I03011rec IL-10 (human)Inquiry
I03012rec IL-10 (murine)Inquiry
I03013rec IL-11 (human)Inquiry
I03014rec IL-1alpha (human)Inquiry
I03015rec IL-1beta (murine)Inquiry
I03016rec IL-2 (human)Inquiry
I03017rec IL-3 (human)Inquiry
I03018rec IL-3 (murine)Inquiry
I03019rec IL-4 (human)Inquiry
I03020rec IL-4 (murine)Inquiry


Interleukins, one kind of lymphokines which is a hormone-like polypeptide substance produced by activated lymphocytes that does not have the structure of an antibody and cannot bind to an antigen. Different lymphokines can express a variety of biological activities, which can act on the corresponding target cells to cause changes in the characteristics or functions of the target cells. Lymphocytes act on adjacent or distant target cells by means of lymphokines, which is parallel with the action of antibodies and is an important way to achieve immune and immune regulation functions. At least 38 kinds of interleukins have been discovered, named IL1~L38, which are complex in function, networked, and complexly overlapped. Interleukin (IL)-2, 3, 4 and 5 are all produced by lymphocytes and belong to the “real” lymphokines while IL-1 and 6 are mainly produced by mononuclear macrophages, and can also be produced by some lymphocyte culture strains, which are both mononuclear cytokines and lymphokines.


Essentially, it is accomplished through the exchange of information between cells, in which lymphokines act as a medium, which seems to be very similar to hormones. The IL-1 and 2 are essential for T-cell proliferation to antigen. T lymphocytes in response to antigen is dependent upon monocytes/macrophages which process and present the antigen and are a source of IL- 1. It is generally held that this stimulates T cells to produce IL-2 and receptors for IL-2; the interaction of IL-2 with its receptor stimulates T-cell proliferation. IL-2 is made by T cells; to date no other cell has been shown to produce this lymphokine. The action of IL-2 is predominantly on T cells or closely related lymphocytes (natural killer, NK, or lymphokine-activated killer cells, LAK), although it also exerts effects on B cells and macrophages. In contrast, IL-l is extremely pleiotropic acting, not only on other lymphoid cells but also on a variety of non-lymphoid targets. What’s more, T lymphocytes produce a number offactors affecting the growth and differentiation of B lymphocytes. Both IL-4 and IL-5 have growth and differentiation activities for B cells and IL-6 differentiation activity. In addition, IL-l and IL-3, as well as IL-2, are reported as promoting B-cell growth and differentiation.


Interleukins play an important role in transmitting information, activating and regulating immune cells, mediating T and B cell activation, proliferation and differentiation, and in inflammatory responses. The IL-2 can induce and enhance cytotoxic activity, and the current research on the treatment of certain diseases with IL-2, especially for cancer treatment, has been widely carried out. In addition, it also can applied to the treatment of viral infections by enhances the activity of CTL and NK cells, induces the production of interferon, and enhances the body's anti-infective immunity. Therefore, people with AIDS and other congenital or acquired cellular immune function have the effect of preventing and treating various viral infections. The IL-3 can be used to treat children with myelodysplastic syndrome, leukemia.

1. Hamblin A. S. (1991). Lymphokines and interleukins. Immunology Supplement, (Suppl1), 39-41.
2. Strober W., & James S. P. (1988). The Interleukins. Pediatr Res, 24 (5), 549-557.

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Copyright © Creative Peptides. All rights reserved.